{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:35:44Z","timestamp":1790048144314,"version":"4.0.1"},"reference-count":53,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2003,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Group B<jats:italic>Streptococcus<\/jats:italic>(GBS) is a major cause of newborn sepsis and meningitis and induces systemic release of tumor necrosis factor alpha (TNF-\u03b1), believed to play a role in morbidity and mortality. While previous studies have shown that GBS can induce TNF-\u03b1 release from monocytes and macrophages, little is known about the potential modulating effect of plasma or serum on GBS-induced TNF-\u03b1 release, and there are conflicting reports as to the host receptors involved. In a human whole-blood assay system, GBS type III COH-1 potently induced substantial monocyte TNF-\u03b1 release in adult peripheral blood and, due to a higher concentration of monocytes, 10-fold-greater TNF-\u03b1 release in newborn cord blood. Remarkably, GBS-induced TNF-\u03b1 release from human monocytes was enhanced \u223c1,000-fold by heat-labile serum components. Experiments employing C2-, C3-, or C7-depleted serum demonstrated that C3 activation via the alternative pathway is crucial for potent GBS-induced TNF-\u03b1 release. Accordingly, whole blood from C3-deficient mice demonstrated significantly reduced GBS-induced TNF-\u03b1 release. Preincubation with human serum enhanced the TNF-\u03b1-inducing activity of GBS in a C3- and factor B-dependent manner, implying deposition of complement components via the alternative pathway. GBS-induced TNF-\u03b1 release was inhibited by monoclonal antibodies directed against each of the components of CR3 and CR4: the common integrin \u03b2 subunit CD18 and the \u03b1 subunits CD11b (of CR3) and CD11c (of CR4). Blood derived from CR3 (CD11b\/CD18)-deficient mice demonstrated a markedly diminished TNF-\u03b1 response to GBS. We conclude that the ability of plasma and serum to greatly amplify GBS-induced TNF-\u03b1 release reflects the activity of the alternative complement pathway that deposits fragments on GBS and thereby enhances CR3- and CR4-mediated monocyte activation.<\/jats:p>","DOI":"10.1128\/iai.71.11.6344-6353.2003","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T02:31:56Z","timestamp":1066962716000},"page":"6344-6353","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":39,"title":["Critical Role of the Complement System in Group B<i>Streptococcus<\/i>-Induced Tumor Necrosis Factor Alpha Release"],"prefix":"10.1128","volume":"71","author":[{"given":"Ofer","family":"Levy","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Children's Hospital"},{"name":"Channing Laboratory, Brigham and Women's Hospital"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle M.","family":"Jean-Jacques","sequence":"additional","affiliation":[{"name":"Channing Laboratory, Brigham and Women's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Cywes","sequence":"additional","affiliation":[{"name":"Channing Laboratory, Brigham and Women's Hospital"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Sisson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kol A.","family":"Zarember","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Genentech, Inc., South San Francisco, California 94080"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Godowski","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Genentech, Inc., South San Francisco, California 94080"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Christianson","sequence":"additional","affiliation":[{"name":"Channing Laboratory, Brigham and Women's Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde-Kari","family":"Guttormsen","sequence":"additional","affiliation":[{"name":"Channing Laboratory, Brigham and Women's Hospital"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Nicholson-Weller","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02115"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Wessels","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Children's Hospital"},{"name":"Channing Laboratory, Brigham and Women's Hospital"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/35021228"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.10.5794-5802.2000"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.4.2053-2060.2000"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5428.736"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI110463"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200105000-00014"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-200203000-00007"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1177\/09680519010070040901"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"7335","DOI":"10.4049\/jimmunol.162.12.7335","volume":"162","year":"1999","unstructured":"Bhat, N., P. Y. Perera, J. M. Carboni, J. Blanco, D. T. Golenbock, T. N. Mayadas, and S. N. Vogel. 1999. Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression. J. Immunol.162:7335-7342.","journal-title":"J. Immunol."},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.4049\/jimmunol.163.5.2761","volume":"163","year":"1999","unstructured":"Butko, P., A. Nicholson-Weller, and M. R. Wessels. 1999. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J. Immunol.163:2761-2768.","journal-title":"J. Immunol."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.6.1978-1983.1991"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.11.4558-4562.1992"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jp.7200360"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.65.8.3255-3260.1997"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.11.5871"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.2.994-998.2000"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1286-4579(00)00299-9"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/322696"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.60.6.901"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.4.2064"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5430.1028"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.7.3970"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.12.7069"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.7.2715-2721.1994"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(01)02004-9"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70078-7"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1086\/315796"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119042"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-065X.2001.1800116.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.1.320-327.2000"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90517-0"},{"key":"e_1_3_2_33_2","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.4049\/jimmunol.160.9.4535","volume":"160","year":"1998","unstructured":"Medvedev, A. E., T. Flo, R. R. Ingalls, D. T. Golenbock, G. Teti, S. N. Vogel, and T. Espevik. 1998. Involvement of CD14 and complement receptors CR3 and CR4 in nuclear factor-\u03baB activation and TNF production induced by lipopolysaccharide and group B streptococcal cell walls. J. Immunol.160:4535-4542.","journal-title":"J. Immunol."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199906103402312"},{"key":"e_1_3_2_35_2","first-page":"440","volume":"84","year":"1995","unstructured":"Peat, E. B., N. H. Augustine, W. K. Drummond, J. F. Bohnsack, and H. R. Hill. 1995. Effects of fibronectin and group B streptococci on tumour necrosis factor-alpha production by human culture-derived macrophages. Immunology84:440-445.","journal-title":"Immunology"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.1.574"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(98)01344-0"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(94)90093-0"},{"key":"e_1_3_2_39_2","first-page":"2","volume":"22","year":"1998","unstructured":"Schelonka, R., and A. Infante. 1998. Neonatal immunology. Semin. Perinatol.22:2-14.","journal-title":"Perinatol."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07128-1"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.25.17406"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.12.6445-6453.1999"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/hh2201.099166"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.1.227-235.1993"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4906(02)02233-0"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(99)80004-1"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/44605"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.12.5042-5046.1996"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.1.419"},{"key":"e_1_3_2_50_2","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.4049\/jimmunol.155.6.3092","volume":"155","year":"1995","unstructured":"Violette, S. M., J. R. Rusche, S. R. Purdy, J. G. Boyd, J. Cos, and S. Silver. 1995. Differences in the binding of blocking anti-CD11b monoclonal antibodies to the A-domain of CD11b. J. Immunol.155:3092-3101.","journal-title":"J. Immunol."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.25.11490"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81706-8"},{"key":"e_1_3_2_53_2","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.4049\/jimmunol.162.4.2281","volume":"162","year":"1999","unstructured":"Xia, Y., V. Vetvicka, J. Yan, M. Hanikyrova, T. Mayadas, and G. D. Ross. 1999. The beta-glucan-binding lectin site of mouse CR3 (CD11b\/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells. J. Immunol.162:2281-2290.","journal-title":"J. Immunol."},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M908868199"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.11.6344-6353.2003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.71.11.6344-6353.2003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T03:51:17Z","timestamp":1704945077000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.71.11.6344-6353.2003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["10.1128\/IAI.71.11.6344-6353.2003"],"URL":"https:\/\/doi.org\/10.1128\/iai.71.11.6344-6353.2003","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"2003-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-08-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2003-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}